Biotech

All Articles

Novartis kindles new phase of Voyager pact with $15M capsid package

.Novartis levels a brand new outpost in its own partnership with Voyager Rehabs, paying out $15 mill...

Lilly articles much more beneficial data on its every week the hormone insulin possibility

.On the heels of an FDA turndown for its own chief competing Novo Nordisk, Eli Lilly is making headw...

IN 8bio halts period 2 test, lays off half of staff

.Just a couple of months after dosing the 1st client in a period 2 trial for newly identified gliobl...

Lilly, Haya ink $1B biobuck obesity treaty to look dark genome

.Eli Lilly's hunt for being overweight intendeds has led it to the dark genome. The Big Pharma has c...

ArsenalBio elevates $325M, rotates away from former lead asset

.Collection Biosciences is carrying on up. The cell therapy company has actually added on $325 milli...

Lilly- backed weight-loss biotech documents IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually s...

Aelis' marijuana use medication flunks period 2b, steering Indivior to reconsider $100M option

.Aelis Farma's hopes of protecting a simple, positive choice on a $one hundred million possibility s...

ProKidney halts period 3 trial not needed for cell treatment permission

.ProKidney has quit some of a pair of period 3 trials for its own tissue treatment for kidney illnes...

Vaxcyte surges on 'impressive' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what professionals named "magnificent" stage 1/2 data for its 31-valent pneumococc...

Recursion's brain disease test reveals insufficient evidence of effectiveness

.Recursion has discovered via an early examination of its tech-enabled strategy to medicine discover...